|
Leukotriene antagonists for first-line or add-on asthma therapy
American Pharmacists Association, pharmacist.com Key point: In patients with asthma, leukotriene-receptor antagonists (LTRAs) managed the disease just as successfully as inhaled glucocorticoid for first-line therapy or long-acting beta-2 agonist as add-on therapy. Finer points: Two parallel, … |
View full post on asthma – Google News